BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35090329)

  • 1. Ischemic index and distribution of retinal capillary non-perfusion in neovascular glaucoma.
    DeBoer C; Wong B; Ameri H
    Front Biosci (Landmark Ed); 2022 Jan; 27(1):24. PubMed ID: 35090329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of neovascular glaucoma. Etiopathogenesis and treatment.
    Dumbrăveanu L; Cușnir V; Bobescu D
    Rom J Ophthalmol; 2021; 65(4):315-329. PubMed ID: 35087972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Panretinal photocoagulation with simultaneous cryoretinopexy or intravitreal bevacizumab for neovascular glaucoma.
    Tatsumi T; Yamamoto S; Uehara J; Sugawara T; Baba T; Inoue M; Hata H; Mitamura Y
    Graefes Arch Clin Exp Ophthalmol; 2013 May; 251(5):1355-60. PubMed ID: 23250484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review of Neovascular Glaucoma: Etiology, Pathogenesis, Diagnosis, and Treatment.
    Urbonavičiūtė D; Buteikienė D; Janulevičienė I
    Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neovascular Glaucoma: An Update.
    Kalogeropoulos D; Moussa G; Sung VC; Pappa C; Kalogeropoulos C
    Klin Monbl Augenheilkd; 2023 Mar; 240(3):305-315. PubMed ID: 36436509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathological association between the anterior eye segment and the retina in a murine model of neovascular glaucoma.
    Nishinaka A; Tanaka M; Aoshima K; Kuriyama A; Sasaki T; Otsu W; Yasuda H; Nakamura S; Shimazawa M; Hara H
    FASEB J; 2022 Jun; 36(6):e22323. PubMed ID: 35485981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual Outcomes in Eyes With Neovascular Glaucoma and Anterior Segment Neovascularization Without Glaucoma.
    Sastry A; Ryu C; Jiang X; Ameri H
    Am J Ophthalmol; 2022 Apr; 236():1-11. PubMed ID: 34562418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neovascular glaucoma - A review.
    Senthil S; Dada T; Das T; Kaushik S; Puthuran GV; Philip R; Rani PK; Rao H; Singla S; Vijaya L
    Indian J Ophthalmol; 2021 Mar; 69(3):525-534. PubMed ID: 33595466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neovascular Glaucoma.
    Havens SJ; Gulati V
    Dev Ophthalmol; 2016; 55():196-204. PubMed ID: 26501989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aqueous Inflammation and Ischemia-Related Biomarkers in Neovascular Glaucoma with Stable Iris Neovascularization.
    Sun C; Zhang H; Tang Y; Chen Y; Li Y; Nie C; Gu J; Luo L; Wang Z
    Curr Eye Res; 2020 Dec; 45(12):1504-1513. PubMed ID: 32339463
    [No Abstract]   [Full Text] [Related]  

  • 11. Two-year outcomes of patients presenting to Sydney Eye Hospital with neovascular glaucoma.
    Kingston EJ; Lusthaus JA
    Int Ophthalmol; 2023 Aug; 43(8):2763-2776. PubMed ID: 36913166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
    Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
    Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neovascular glaucoma: a review.
    Rodrigues GB; Abe RY; Zangalli C; Sodre SL; Donini FA; Costa DC; Leite A; Felix JP; Torigoe M; Diniz-Filho A; de Almeida HG
    Int J Retina Vitreous; 2016; 2():26. PubMed ID: 27895936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism and therapeutic strategies for neovascular glaucoma secondary to diabetic retinopathy.
    Tang Y; Shi Y; Fan Z
    Front Endocrinol (Lausanne); 2023; 14():1102361. PubMed ID: 36755912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neovascular Glaucoma from Ocular Ischemic Syndrome Treated with Serial Monthly Intravitreal Bevacizumab and Panretinal Photocoagulation: A Case Report.
    Asif H; Si Z; Quan S; Amin P; Dao D; Shaw L; Skondra D; Qiu M
    Case Rep Ophthalmol Med; 2022; 2022():4959522. PubMed ID: 35935916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Features of Ocular Ischemic Syndrome and Risk Factors for Neovascular Glaucoma.
    Kim YH; Sung MS; Park SW
    Korean J Ophthalmol; 2017 Aug; 31(4):343-350. PubMed ID: 28682017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pars plana vitrectomy and panretinal photocoagulation combined with trabeculectomy for successful treatment of neovascular glaucoma.
    Kiuchi Y; Nakae K; Saito Y; Ito S; Ito N
    Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1627-32. PubMed ID: 16639623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-vascular endothelial growth factor for neovascular glaucoma.
    Simha A; Braganza A; Abraham L; Samuel P; Lindsley K
    Cochrane Database Syst Rev; 2013 Oct; 10(10):CD007920. PubMed ID: 24089293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neovascular glaucoma: etiology, diagnosis and prognosis.
    Shazly TA; Latina MA
    Semin Ophthalmol; 2009; 24(2):113-21. PubMed ID: 19373696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Neovascular Glaucoma in Central Retinal Vein Occlusion.
    Rong AJ; Swaminathan SS; Vanner EA; Parrish RK
    Am J Ophthalmol; 2019 Aug; 204():62-69. PubMed ID: 30862502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.